Tushar Adhikari | Phytochemistry | Research Excellence Award

Published on by sciencefatherLeave a Comment on Tushar Adhikari | Phytochemistry | Research Excellence Award

Mr. Tushar Adhikari | Phytochemistry | Research Excellence Award

Guru Nanak Institute of Pharmaceutical Science and Technology | India

Mr. Tushar Adhikari is an emerging academic and researcher in the field of pharmaceutical sciences, with a strong foundation in pharmaceutical chemistry and phytochemistry. He completed his M.Pharm. with a specialization in Pharmaceutical Chemistry from Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, securing First Class Honours, following his B.Pharm. from Adamas University with First Class Honours. His academic journey reflects consistent excellence from secondary education through postgraduate studies. Since August 2022, he has been serving as an Assistant Professor at Guru Nanak Institute of Pharmaceutical Science and Technology, where he has accumulated over 1.5 years of teaching, research, and administrative experience. His research interests are primarily centered on phytochemistry, with hands-on expertise in extraction, fractionation, isolation, purification, and characterization of bioactive phytoconstituents, particularly flavonoids, using advanced chromatographic and spectroscopic techniques such as HPTLC, TLC, column chromatography, UV, IR, and AAS. In addition, he has exposure to computer-aided drug design, including molecular docking, 2D and 3D QSAR, and pharmacophore modeling. His academic distinctions, teaching contributions, and interdisciplinary research orientation highlight his commitment to advancing pharmaceutical education and research, positioning him as a promising contributor to future innovations in drug discovery and natural product research.

Featured Publications


Phytochemistry and Pharmacological Potential of Alocasia macrorrhiza: A Comprehensive Review

– Journal of Applied Pharmaceutical Research, 2024, Vol. 12 (Issue 6)

Yanpeng Li | Pharmacology | Research Excellence Award

Published on by sciencefatherLeave a Comment on Yanpeng Li | Pharmacology | Research Excellence Award

Dr. Yanpeng Li | Pharmacology | Research Excellence Award

Shenzhen University | China

Dr. Yanpeng Li is a pharmacology researcher at Shenzhen University with interdisciplinary expertise spanning pharmaceutical chemistry, immunology, and targeted drug discovery. He earned his PhD in Pharmacology from Southern Medical University and completed joint doctoral training at the Karolinska Institutet under Nobel Committee member Prof. Rikard Holmdahl, where his research centered on natural medicinal flavonoids, particularly kaempferol, in autoimmune diseases and virus immunology. Dr. Li further strengthened his international research profile through postdoctoral training in viral immunology at the Karolinska Institutet and is currently pursuing postdoctoral research at Shenzhen University, focusing on targeted therapeutic strategies for acute myeloid leukemia. His academic and professional journey reflects a strong integration of basic pharmacological mechanisms with translational drug development. Dr. Li is an active member of several professional bodies, including the Editorial Board of the International Conference on Disease Genetics and Genomics, the Clinical Rational Drug Use Committee of the Shenzhen Medical Doctor Association, and the Swedish Pharmacists’ Association. His research interests encompass natural compounds, autoimmune disorders such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, viral immunology, acute myeloid leukemia, and precision-targeted therapies. In recognition of his academic excellence, he has received multiple scholarships and awards from institutions in China and Sweden. Overall, Dr. Li’s work contributes significantly to advancing targeted therapeutics and evidence-based pharmacological innovation.

View ORCID Profile

Featured Publications

Camilla Djenne Buarque Muller | Medicinal Chemistry | Best Researcher Award

Published on by sciencefather

Prof. Dr. Camilla Djenne Buarque Muller | Medicinal Chemistry | Best Researcher Award

PUC-Rio | Brazil

Prof. Dr. Camilla Djenne Buarque Müller is a distinguished Brazilian chemist recognized for her impactful contributions to synthetic organic chemistry, natural products chemistry, and medicinal chemistry. She earned her Ph.D. and M.Sc. in Chemistry from the Federal University of Rio de Janeiro (UFRJ), where she conducted innovative research on pterocarpans, aza-pterocarpans, and palladium-catalyzed arylation strategies. Her academic career includes key faculty positions at the Pontifical Catholic University of Rio de Janeiro (PUC-Rio), where she progressed from Assistant Professor to Associate Professor, and currently continues her scientific leadership at Fluminense Federal University (UFF). Prof. Müller has also held important roles within the Brazilian Chemical Society (SBQ), serving as Vice-Secretary and Secretary of SBQ-Rio. Her research interests span heterocyclic synthesis, triazole hybrids, CFTR modulator development, covalent organic frameworks, and structure-activity relationships applied to drug discovery. She has received numerous prestigious honors, including Research Productivity Fellowships (CNPq), Scientist of Our State (FAPERJ), Young Scientist of Our State, Best Poster Awards, and multiple recognitions for excellence in undergraduate and graduate supervision. Prof. Müller continues to advance chemistry through impactful publications, mentorship, and contributions that strengthen Brazil’s scientific community.

Profiles: Scopus | Orcid

Featured Publications

Zeitune, D. C., Azevedo, M. F. M. F., Rangel, M. S., Bastos, R. de S., Neto, J. de B. V., Pessoa, C. do Ó., & Buarque, C. D. (2025). Synthesis and antitumoral activity of novel biaryl hydroxy-triazole and fluorene-triazole hybrids. Exploration of Drug Science.

Carneiro, L. S. A., & Buarque, C. D. (2025). Arylation of C=C bonds via non-cross-coupling reactions: historical evolution of the Meerwein arylation mechanisms. ChemTexts.

Azevedo, M. F. M. F., Zeitune, D. C., de Farias, R. L., Junior, E. N. C., Bacalhau, M., Amaral, M. D., Lopes-Pacheco, M., & Buarque, C. D. (2025). Direct access of 4-acyl-1,2,3-triazoles from acetophenones: A synthetic shortcut for novel p.Phe508del-CFTR traffic correctors. Journal of Molecular Structure.

Bacalhau, M., Ferreira, F. C., Azevedo, M. F. M. F., Rosa, T. P., Buarque, C. D., & Lopes-Pacheco, M. (2025). Rescue of mutant CFTR channel activity by investigational co-potentiator therapy. Biomedicines.

Cifuentes, J. M. C., Henrique, F. J. F. S., Ligiéro, C. B. P., Esteves, P. M., & Buarque, C. D. (2024). Covalent organic frameworks as a versatile platform for iron-catalyzed sp³ C–H activation and cross-coupling via decarboxylative oxidation. European Journal of Inorganic Chemistry.

Ferreira, F., Buarque, C., & Lopes-Pacheco, M. (2024). Organic synthesis and current understanding of the mechanisms of CFTR modulator drugs Ivacaftor, Tezacaftor, and Elexacaftor. Molecules.

da Silva, V. D., Zalewska, K., Petrovski, Z., Buarque, C. D., Branco, L. C., & Esteves, P. M. (2023). Covalent organic frameworks as promising materials for the removal of metal and organic pollutants from water. Materials Today Sustainability.

Dr. Hardik Varu | Analytical Chemistry | Best Researcher Award

Published on by sciencefather

Dr. Hardik Varu | Analytical Chemistry | Best Researcher Award

Dr. Subhash University, Junagadh | India

Dr. Hardik Varu is an accomplished chemist and academician with expertise in analytical and pharmaceutical chemistry. He earned his Doctor of Philosophy (Ph.D.) in Chemistry from Bhakta Kavi Narsinh Mehta University, Junagadh, focusing on “Method Development, Validation and Analytical Studies of Bioactive Compounds,” following a Master of Science in Analytical Chemistry and a Bachelor of Science in Chemistry. Currently serving as an Assistant Professor at Dr Subhash University, Junagadh, he has previously worked as a Teaching Assistant at his alma mater, contributing to both undergraduate and postgraduate education. His teaching spans Regulatory Affairs, Spectroscopy & Chromatography, and Pharmaceutical Technology. Dr. Varu possesses extensive technical expertise in operating advanced instrumentation, including UV-Vis spectrophotometers, FTIR, fluorescence spectrophotometers, flame photometers, and UHPLC systems, alongside proficiency in scientific software such as Origin, ChemDraw, Mnova, and research database tools. His research interests focus on analytical method development, bioactive compound analysis, and pharmaceutical applications. Recognized for his excellence, he has received awards including Academic Excellence, fellowships, and multiple SSIP grants, as well as conference distinctions. With a commitment to academic innovation, research advancement, and mentorship, Dr. Varu continues to contribute significantly to the scientific community.

Profiles: Orcid | Google Scholar

Featured Publications

Vavaiya, P.P.; Malviya, N.J.; Alshehri, A.A.; Alqarni, M.; Varu, H.L. (2026). “The reaction of Ninhydrin Revisited: applications in quantification of analytes, active pharmaceutical ingredients and amino acids” in Journal of Molecular Structure.

Varu, H.L.; Parmar, H.N.; Vadhel, H.D.; Ambasana, M.A. (2025). “A Comprehensive Review of Analytical Methodologies for Memantine Hydrochloride” in Journal of Analytical Chemistry.

Varu, H.L.; Bapodra, A.H.; Ambasana, M. (2024). “First Order Derivative Spectroscopic Evaluation of Carfilzomib in Parenteral Preparation” in Indian Journal of Pharmaceutical Sciences.

Vachhani, D.; Parekh, J.H.; Patra, S.; Varu, H.L.; Soni, M.; Jebaliya, H.J. (2024). “Green Analytical Method Development and Validation Studies of Viloxazine Hydrochloride in Pure and Commercial Products Using UV-Vis Spectroscopy” in Journal of Applied Spectroscopy.

Varu, H.L.; Nariya, P.B.; Patel, A.S.; Gadher, M.; Makhasana, M.; Lunagariya, K.; Tirvedi, B.; Ambasana, M.A. (2024). “High-performance thin-layer chromatography‒spectrodensitometric determination of diltiazem hydrochloride and its commonly occurring degradation impurity” in Journal of Planar Chromatography – Modern TLC.

Varu, H.L.; Kapuriya, N.P.; Bhalodia, J.J.; Bapodra, A.H.; Ambasana, M.A. (2024). “Kinetic Spectrophotometric Determination of Memantine Hydrochloride Based on the Formation of Its Dinitrochlorobenzene Adduct” in Journal of Analytical Chemistry.

Joshi, R.J.; Dholariya, M.P.; Chothani, S.R.; Chamakiya, C.A.; Varu, H.L.; Karmur, M.B.; Maliwal, D.; Pissurlenkar, R.R.S.; Bapodra, A.H.; Patel, A.S.; et al. (2024). “Synthesis, antidiabetic activity and in silico studies of benzo[b]thiophene based small molecule α-amylase inhibitors” in Journal of Molecular Structure.

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Published on by sciencefather

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Wuhan University - China

Author Profile

Early Academic Pursuits

Ms. Yufang Ma's academic journey began with a fervent interest in the biomedical sciences. She completed her undergraduate studies with a focus on pharmacology, where she developed a strong foundation in understanding drug interactions and biological systems. Her early research interests centered around natural compounds, particularly flavonoids, which are known for their diverse pharmacological properties. This interest led her to delve deeper into the conformational relationships of these compounds, exploring how their structures influence their biological activities. Her dedication to her studies was reflected in her academic excellence and active participation in various research initiatives.

Professional Endeavors

Following her undergraduate studies, Ms. Yufang Ma pursued a Master's degree at Wuhan University, one of the top institutions in China. Her professional endeavors have been marked by her commitment to advancing pharmacological research. At Wuhan University, she has been primarily engaged in studying the conformational relationships of flavonoids and their pharmacological effects. Her research aims to uncover the therapeutic potential of these natural compounds, particularly in the context of treating neurological disorders such as epilepsy. This work not only contributes to the scientific community's understanding of flavonoids but also has the potential to lead to the development of new, effective treatments for epilepsy.

Contributions and Research Focus

Ms. Yufang Ma's contributions to pharmacological research are centered on her in-depth studies of flavonoids. Her primary research focus involves investigating the conformational relationships of these compounds and how their structural variations impact their pharmacological properties. She is particularly interested in the therapeutic potential of flavonoids in treating epilepsy, a neurological disorder characterized by recurrent seizures. Through her research, she aims to identify specific flavonoids that can modulate neuronal activity and reduce seizure frequency. This focus on epilepsy research is a significant contribution to the field, as it addresses a critical need for new, effective treatments for this debilitating condition.

Accolades and Recognition

While Yufang Ma's work is ongoing, she has already garnered recognition for her contributions to pharmacological research. Her dedication to exploring the therapeutic potential of flavonoids has been acknowledged by her peers and mentors at Wuhan University. Although she has not yet published extensively or secured patents, her research on epilepsy is paving the way for significant advancements in the field. The recognition she has received serves as a testament to her potential to make impactful contributions to pharmacology and therapeutics.

Impact and Influence

The impact of Yufang Ma's research extends beyond the academic community. Her work on flavonoids and epilepsy has the potential to influence the development of new pharmacological treatments. By identifying specific flavonoids with anticonvulsant properties, her research could lead to the creation of novel therapies that offer better efficacy and fewer side effects compared to existing treatments. This potential impact highlights the broader significance of her work in improving patient outcomes and enhancing the quality of life for individuals with epilepsy.

Legacy and Future Contributions

Ms. Yufang Ma's legacy in pharmacological research is still in the making, but her ongoing work promises to leave a lasting impact on the field. As she continues to explore the therapeutic potential of flavonoids, her findings could pave the way for new treatment paradigms in epilepsy and other neurological disorders. Her future contributions are likely to extend beyond research, potentially influencing clinical practices and drug development strategies. With her dedication and innovative approach, Ms. Yufang Ma is poised to become a leading figure in pharmacology, contributing to the advancement of science and the improvement of human health.

Notable Publication

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity, 2024.

Diosmetin Ameliorates HFD-induced Cognitive Impairments via Inhibiting Metabolic Disorders, Mitochondrial Dysfunction and Neuroinflammation in Male SD Rats, 2024